Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 271-280 of 284 for

Edit search filters
  1. Alpha-1 AD Carriers and Lung Cancer Risk

    Rochester, MN

  2. Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes

    Scottsdale/Phoenix, AZ

  3. A Study to Evaluate Plasma and Sputum As Noninvasive Biomarkers for Bronchial Dysplasia Progression/Regression

  4. A Study of Response Rate and Survival from Combined Chemotherapy, Surgery and Radiation Therapy for Patients with Malignant Mesothelioma

    Rochester, MN

  5. A Study to Collect Medical Data and Tissue from Patients with Lung Conditions Resulting in Lung Surgery.

    Rochester, MN

  6. A Study to Develop a Decision Aid for Patients Having Lung Screening

    Rochester, MN

  7. A Study Identifying Predictive Biomarkers for the Progression of Invasive Squamous Cell Carcinoma

    Rochester, MN

  8. A Study to Evaluate Heart Failure Biomarker to Predict Cardiomyopathy After Acute Radiation

    Jacksonville, FL

  9. Therapeutic Drug Monitoring of Pembrolizumab and Nivolumab to Determine Dosages for Cancer Treatment

    Rochester, MN

  10. A Study to Explore the Mechanisms that Separate Responders Versus Non-responders to Treatment such as Immunotherapy, Target Therapy and Chemotherapy in Lung Cancer Patients

    Jacksonville, FL

.

Mayo Clinic Footer